Atlas FDA

MEDTRONIC INTERSTIM THERAPY FOR BOWEL CONTROL

FDA premarket approval P080025/S068 · decided 2014-10-17

Approval details

PMA number
P080025
Supplement
S068
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MEDTRONIC INTERSTIM THERAPY FOR BOWEL CONTROL
Generic name
Implanted electrical device intended for treatment of fecal incontinence
Applicant
Medtronic Neuromodulation
Date received
2014-04-21
Decision date
2014-10-17
Days to decision
179 days
Decision code
APPR
Product code
QON
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
APPROVAL FOR CHANGES TO THE MODEL 3037 ICON PATIENT CONTROLLER USED FOR MEDTRONIC INTERSTIM THERAPY FOR URINARY CONTROL AND BOWEL CONTROL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23